RapidAI Raises $75M To Help Diagnose Strokes

Every industry will be impacted by the rise of artificial intelligence, and that certainly will include health care in a big way.

became the latest startup to raise a significant amount of money to help with how we care for ourselves using AI.

The San Mateo, California-based company, whose platform uses AI to help diagnose neurovascular, cardiac and vascular diseases, closed a $75 million Series C funding led by , a subsidiary of .

Search less. Close more.

Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data.

RapidAI鈥檚 Rapid NCCT Stroke platform gives hospitals imaging and decision support to address possible strokes 鈥� . The company also has developed modules for cerebral aneurysm management and the identification and notification of a suspected central pulmonary embolism. It hopes to eventually also address other diseases.

鈥淗ospitals are increasingly looking for RapidAI solutions to solve their critical needs, including helping care teams work more efficiently and support clinical decision making for better patient outcomes,鈥� CEO said in a .

Founded in 2011, the company has now raised $100 million, .

AI in health care

RapidAI is not the only AI-enhanced, health-related startup to see fresh funding from investors hoping to eventually cash in on the intersection of two big sectors: AI and health care.

Seattle-based announced a $43 million Series B, also on Thursday. The startup has developed an AI-driven surgical navigation platform that generates a real-time 3D visualization of the surgery.

Earlier this month, London-based closed a $60 million Series B. The company has created an AI-enhanced platform to help accelerate drug discovery.

With artificial intelligence investment hitting a fever pitch, expect more deals in the health care space when it involves AI-enriched platforms and insights.